Now reimagining home, office schedules: Novartis CEO Vas Narasimhan sees a new normal in the post-Covid era
It’s not just small biotechs that are looking to completely reevaluate their need for office space in a post-Covid world. It turns out Novartis CEO Vas Narasimhan is also reimagining the Big Pharma footprint in the commercial real estate world.
“We’ve all learned from the pandemic that we can work from home and work from the office, and it will always be a combination going forward,” Narasimhan told Bloomberg Television in an interview.
This article is for premium subscribers only
Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.